CSIMarket



Abbott Laboratories  (ABT)
Other Ticker:  
 
 

ABT's EPS from Cont. Operations Growth by Quarter and Year

Abbott Laboratories's EPS from Cont. Operations results by quarter and year




ABT EPS from Cont. Operations (in $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 1.12 1.22 0.59
III Quarter September - 1.18 0.69 0.54
II Quarter June - 0.67 0.30 0.57
I Quarter March 1.38 1.00 0.31 0.38
FY   1.38 3.97 2.52 2.08



ABT EPS from Cont. Operations first quarter 2022 Y/Y Growth Comment
Abbott Laboratories achieved in the first quarter 2022, above Company average EPS from Cont. Operations growth of 38% year on year, to $ 1.38 .

Looking into first quarter 2022 results within Major Pharmaceutical Preparations industry 7 other companies have achieved higher EPS from Cont. Operations growth. While Abbott Laboratories' s EPS from Cont. Operations rise of 38% ranks overall at the positon no. 435 in the first quarter 2022.




ABT EPS from Cont. Operations ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - -8.2 % 106.78 % 59.46 %
III Quarter September - 71.01 % 27.78 % 74.19 %
II Quarter June - 123.33 % -47.37 % 39.02 %
I Quarter March 38 % 222.58 % -18.42 % 65.22 %
FY   - 57.54 % 21.15 % 57.58 %

Financial Statements
Abbott Laboratories's first quarter 2022 EPS from Cont. Operations $ 1.38 ABT's Income Statement
Abbott Laboratories's first quarter 2021 EPS from Cont. Operations $ 1.00 Quarterly ABT's Income Statement
New: More ABT's historic EPS from Cont. Operations Growth >>


ABT EPS from Cont. Operations (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - -5.08 % 76.81 % 9.26 %
III Quarter September - 76.12 % 130 % -5.26 %
II Quarter June - -33 % -3.23 % 50 %
I Quarter March 23.21 % -18.03 % -47.46 % 2.7 %
FY (Year on Year)   - 57.54 % 21.15 % 57.58 %




EPS from Cont. Operations first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #8
Healthcare Sector #29
Overall #435

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
193.33 % 5.45 % -84.17 %
(Dec 31 2018)   (Dec 31 2017)
EPS from Cont. Operations first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #8
Healthcare Sector #29
Overall #435
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
193.33 % 5.45 % -84.17 %
(Dec 31 2018)   (Dec 31 2017)

EPS from Cont. Operations by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Abbott Laboratories's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
900 % 31.09 % -91.3 %
(Jun 30 2016)   (Mar 31 2016)


ABT's I. Quarter Q/Q EPS from Cont. Operations Comment
Abbott Laboratories achieved in the I. Quarter 2022 below company average EPS from Cont. Operations jump of 23.21% quarter on quarter, to $ 1.38 .

Even if the I. Quarter 2022 ABT's performance was below the regular , this has been yet promising news, as the I. Quarter expension, eclipses the -18.03% EPS from Cont. Operations surge in the I. Quarter a year ago

Within Major Pharmaceutical Preparations industry 15 other companies have achieved higher EPS from Cont. Operations quarter on quarter growth. While Abbott Laboratories's EPS from Cont. Operations growth quarter on quarter, overall rank is 626.


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #16
Healthcare Sector #37
Overall #626
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #16
Healthcare Sector #37
Overall #626
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
900 % 31.09 % -91.3 %
(Jun 30 2016)   (Mar 31 2016)


ABT's I. Quarter Q/Q EPS from Cont. Operations Comment
Abbott Laboratories achieved in the I. Quarter 2022 below company average EPS from Cont. Operations jump of 23.21% quarter on quarter, to $ 1.38 .

Even if the I. Quarter 2022 EPS from Cont. Operations quarter on quarter growth was beneath the regular of 31.09 %, that was still encouraging sign, as the current expension, outshines the -18.03% EPS from Cont. Operations surge in the I. Quarter 2021

Within Major Pharmaceutical Preparations industry 15 other companies have achieved higher EPS from Cont. Operations quarter on quarter growth. While Abbott Laboratories's EPS from Cont. Operations growth quarter on quarter, overall rank is 626.


Abbott Laboratories's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative EPS from Cont. Operations 12 Months Ending $ 4.35 $ 3.97 $ 4.07 $ 3.58 $ 3.21
Y / Y EPS from Cont. Operations Growth (TTM) 35.62 % 57.69 % 114.85 % 105.23 % 59.32 %
Year on Year EPS from Cont. Operations Growth Overall Ranking # 522 # 229 # 310 # 419 # 412
Seqeuential EPS from Cont. Operations Change (TTM) 9.57 % -2.4 % 13.7 % 11.54 % 27.41 %
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # 435 # 737 # 542 # 1068 # 530




Cumulative EPS from Cont. Operations growth Comment
Assuming the Abbott Laboratories's fiscal year would have ended in Mar 31 2022, Abbott Laboratories would have reprted above average annual EPS from Cont. Operations rise of 35.62% year on year, of $ 4 .
This marks a slow-down of the companys growth trends and from the 57.69% increase in Dec 31 2021.

Within the Healthcare sector 34 other companies have achieved higher trailing twelve month EPS from Cont. Operations growth. While EPS from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 229 to 522.

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
193.33 %
5.45 %
-84.17 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 8
Healthcare Sector # 35
Overall # 522

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
635 %
33 %
-77.53 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 29
S&P 500 # 435
Cumulative EPS from Cont. Operations growth Comment
Assuming the Abbott Laboratories's fiscal year would have ended in Mar 31 2022, Abbott Laboratories would have reprted above average annual EPS from Cont. Operations rise of 35.62% year on year, of $ 4 .
This marks a slow-down of the companys growth trends and from the 57.69% increase in Dec 31 2021.

Within the Healthcare sector 34 other companies have achieved higher trailing twelve month EPS from Cont. Operations growth. While EPS from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 229 to 522.

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
193.33 %
5.45 %
-84.17 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 8
Healthcare Sector # 35
Overall # 522

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
635 %
33 %
-77.53 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 29
S&P 500 # 435




Other EPS from Cont. Operations Growth
Major Pharmaceutical Preparations Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
ABT's EPS from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for ABT's Competitors
EPS from Cont. Operations Growth for Abbott Laboratories's Suppliers
EPS from Cont. Operations Growth for ABT's Customers

You may also want to know
ABT's Annual Growth Rates ABT's Profitability Ratios ABT's Asset Turnover Ratio ABT's Dividend Growth
ABT's Roe ABT's Valuation Ratios ABT's Financial Strength Ratios ABT's Dividend Payout Ratio
ABT's Roa ABT's Inventory Turnover Ratio ABT's Growth Rates ABT's Dividend Comparisons



Companies with similar EPS from Cont. Operations increase for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Mar 31 2022
Becton Dickinson And Company58.95%$ 58.947 
Repligen Corp57.41%$ 57.407 
Iqvia Holdings Inc 54.05%$ 54.054 
Conmed Corporation50.00%$ 50.000 
Charles River Laboratories International inc 49.59%$ 49.593 
Phibro Animal Health Corp46.67%$ 46.667 
Prestige Consumer Healthcare Inc 45.71%$ 45.708 
Medpace Holdings Inc 44.63%$ 44.628 
Tenet Healthcare Corp41.76%$ 41.758 
Eli Lilly And Company41.61%$ 41.611 
Abbott Laboratories38.00%$ 38.000 
Abcellera Biologics Inc 37.21%$ 37.209 
Merck and Co Inc 34.92%$ 34.921 
The Pennant Group Inc 33.33%$ 33.333 
Bio techne Corp31.36%$ 31.356 
Abbvie Inc 26.00%$ 26.000 
Co diagnostics Inc 25.00%$ 25.000 
Syneos Health Inc 21.62%$ 21.622 
Mettler Toledo International Inc19.19%$ 19.189 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CCNC's Profile

Stock Price

CCNC's Financials

Business Description

Fundamentals

Charts & Quotes

CCNC's News

Suppliers

CCNC's Competitors

Customers & Markets

Economic Indicators

CCNC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071